Our real-world data reaffirmed that thrombocytopenia is a significant adverse event that affects the continuation of NIRA and requires careful monitoring. Adjusting the start time to ensure an adequate baseline PLT may help mitigate this risk, but larger-scale studies are needed to validate these findings.
Building similarity graph...
Analyzing shared references across papers
Loading...
Mika Mizuno
Mai Nakazono
Mika Fukuda
Taiwanese Journal of Obstetrics and Gynecology
Kagoshima University
Building similarity graph...
Analyzing shared references across papers
Loading...
Mizuno et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69a75bf0c6e9836116a242ec — DOI: https://doi.org/10.1016/j.tjog.2025.04.024